4.2 Article

Diagnostic and service impact of genomic testing technologies in a neonatal intensive care unit

Journal

JOURNAL OF PAEDIATRICS AND CHILD HEALTH
Volume 55, Issue 11, Pages 1309-1314

Publisher

WILEY
DOI: 10.1111/jpc.14398

Keywords

diagnostic yield; exome sequencing; microarray; neonatal intensive care unit

Categories

Ask authors/readers for more resources

Aim To investigate the diagnostic and service impact of chromosomal microarray and whole exome sequencing (WES) in a neonatal intensive care unit (NICU). Methods This was a retrospective medical record review of NICU patients referred for genetics consultation at three time points over a 9-year period at a single centre to determine referral indications, genetic consultation outcomes and time to diagnosis. Results The number of NICU patients referred for genetics consultation increased from 44 in 2007 to 95 in 2015. The proportion of NICU patients suspected of having a genetic condition following clinical geneticist assessment remained stable, averaging 5.3% of all admissions. The proportion of patients receiving a confirmed diagnosis rose from 21% in 2007 to 53% in 2015, with a shift from primarily chromosomal abnormalities to a broad range of monogenic disorders, increasingly diagnosed by WES as a first-tier test. The average age at diagnosis in 2015 was 19 days (range 12-38 days) for chromosomal abnormalities and 138 days (range 10-309 days) for monogenic conditions. Conclusions The adoption of new genetic technologies at our centre has increased the proportion of patients receiving a confirmed genetic diagnosis. This study provides important benchmark data to measure further improvements as turn-around times for genomic testing decrease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Developmental

The Cost of Raising Individuals with Fragile X or Chromosome 15 Imprinting Disorders in Australia

Emma K. Baker, Sheena Arora, David J. Amor, Perrin Date, Meagan Cross, James O'Brien, Chloe Simons, Carolyn Rogers, Stephen Goodall, Jennie Slee, Chris Cahir, David E. Godler

Summary: This study compared the costs associated with raising a child with four rare disorders (Prader-Willi, Angelman, Chromosome 15q Duplication, and fragile X syndromes) and examined the relationship between these costs and clinical severity. The study found that intellectual functioning negatively predicted total costs, and the impact of intellectual functioning on total costs was significantly different in individuals with Angelman syndrome compared to other syndromes.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2023)

Article Ethics

Non-Invasive Prenatal Testing for Non-Medical Traits: Ensuring Consistency in Ethical Decision-Making

Hilary Bowman-Smart, Christopher Gyngell, Cara Mand, David J. Amor, Martin B. Delatycki, Julian Savulescu

Summary: The article discusses the potential use of noninvasive prenatal testing (NIPT) for testing non-medical traits, presenting arguments against and in favor of permitting such use. The objections to permitting these uses include practical problems and negative impacts on the child, family, and society, while the arguments for permitting them include reproductive liberty and autonomy, as well as the principle of procreative beneficence.

AMERICAN JOURNAL OF BIOETHICS (2023)

Article Genetics & Heredity

In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting FOXP2

Lottie D. Morison, Elisabeth Meffert, Miriam Stampfer, Irene Steiner-Wilke, Brigitte Vollmer, Katrin Schulze, Tracy Briggs, Ruth Braden, Adam Vogel, Daisy Thompson-Lake, Chirag Patel, Edward Blair, Himanshu Goel, Samantha Turner, Ute Moog, Angelika Riess, Frederique Liegeois, David A. Koolen, David J. Amor, Tjitske Kleefstra, Simon E. Fisher, Christiane Zweier, Angela T. Morgan

Summary: Disruptions of FOXP2 can cause severe speech disorder known as childhood apraxia of speech (CAS). This study examined individuals with pathogenic FOXP2-only variants and found that speech disorders, including CAS, were prevalent in these cases. Other comorbidities such as feeding difficulties, motor impairment, anxiety, depression, and sleep disturbance were also observed. The study emphasizes the importance of FOXP2 in understanding the neurobiological basis of speech disorder.

JOURNAL OF MEDICAL GENETICS (2023)

Article Biochemistry & Molecular Biology

Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development

Antony Kaspi, Michael S. Hildebrand, Victoria E. Jackson, Ruth Braden, Olivia van Reyk, Tegan Howell, Simone Debono, Mariana Lauretta, Lottie Morison, Matthew J. Coleman, Richard Webster, David Coman, Himanshu Goel, Mathew Wallis, Gabriel Dabscheck, Lilian Downie, Emma K. Baker, Bronwyn Parry-Fielder, Kirrie Ballard, Eva Harrold, Shaun Ziegenfusz, Mark F. Bennett, Erandee Robertson, Longfei Wang, Amber Boys, Simon E. Fisher, David J. Amor, Ingrid E. Scheffer, Melanie Bahlo, Angela T. Morgan

Summary: This study identified new candidate genes associated with childhood apraxia of speech (CAS) through genome sequencing and bioinformatic analysis. The findings highlight the roles of chromatin organization and gene regulation in CAS, and confirm co-expression of CAS-related genes during brain development.

MOLECULAR PSYCHIATRY (2023)

Article Genetics & Heredity

Tissue mosaicism, FMR1 expression and intellectual functioning in males with fragile X syndrome

Emma K. Baker, Marta Arpone, Minh Bui, Claudine M. Kraan, Ling Ling, David Francis, Mathew F. Hunter, Carolyn Rogers, Michael J. Field, Lorena Santa Maria, Victor Faundes, Bianca Curotto, Paulina Morales, Cesar Trigo, Isabel Salas, Angelica M. Alliende, David J. Amor, David E. Godler

Summary: This study found significant associations between FMR1 methylation levels in blood and buccal epithelial cells and FMR1 mRNA levels and intellectual functioning in males with FXS, with stronger relationships seen using MS-QMA compared to mSB.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Genetics & Heredity

Further delineation of dosage-sensitive K/L mediated Xq28 duplication syndrome includes incomplete penetrance

Melanie Leffler, Louise Christie, Anna Hackett, Bruce Bennetts, Himanshu Goel, David J. Amor, Greg B. Peters, Michael Field, Tracy Dudding-Byth

Summary: The low copy tandem repeat area at Xq28 is prone to recurrent copy number gains, including the K/L mediated duplications of 300 kb size (herein described as the K/L mediated Xq28 duplication syndrome). We describe five families, including nine males with K/L mediated Xq28 duplications, some with regions of greater copy number variation (CNV). We summarise findings in 25 affected males reported to date.

CLINICAL GENETICS (2023)

Article Biochemistry & Molecular Biology

Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature

Miya St John, Olivia van Reyk, David A. Koolen, Bert B. A. de Vries, David J. Amor, Angela T. Morgan

Summary: This study provides a detailed characterization of speech and language impairment in Koolen-de Vries syndrome (KdVS). It defines the medical and neurodevelopmental phenotype in the largest cohort of KdVS individuals to date, highlighting the core features of intellectual disability, eye anomalies, structural brain anomalies, and dental problems. While most individuals with KdVS can speak, some use augmentative and alternative communication methods. The study also reveals relative weaknesses in language, literacy, and social skills, and relative strengths in social competence and coping skills.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability

David I. Francis, Zornitza Stark, Ingrid E. Scheffer, Tiong Yang Tan, Krithika Murali, Lyndon Gallacher, David J. Amor, Himanshu Goel, Lilian Downie, Chloe A. Stutterd, Emma I. Krzesinski, Anand Vasudevan, Ralph Oertel, Vida Petrovic, Amber Boys, Vivian Wei, Trent Burgess, Karen Dun, Karen L. Oliver, Anne Baxter, Anna Hackett, Samantha Ayres, Sebastian Lunke, Paul Kalitsis, Meaghan Wall

Summary: This study aimed to compare the diagnostic yield of saliva and blood for pathogenic copy number variants (CNVs). The results showed that saliva microarray testing had increased diagnostic utility over blood testing in individuals with syndromic intellectual disability (ID). Mosaic pathogenic CNVs or aneuploidy were detected in saliva but not in blood.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Endocrinology & Metabolism

MOGS-CDG: Quantitative analysis of the diagnostic Glc3Man tetrasaccharide and clinical spectrum of six new cases

Merel A. A. Post, Isis de Wit, Fokje S. M. Zijlstra, Udo F. H. Engelke, Arno van Rooij, John Christodoulou, Tiong Yang Tan, Anna Le Fevre, Danqun Jin, Joy Yaplito-Lee, Beom Hee Lee, Karen J. J. Low, Andrew A. A. Mallick, Katrin Ounap, James Pitt, William Reardon, Mari-Anne Vals, Saskia B. B. Wortmann, Hans J. C. T. Wessels, Melissa Barenfanger, Clara D. M. van Karnebeek, Dirk J. J. Lefeber

Summary: Congenital disorders of glycosylation (CDG) are a diverse group of inherited metabolic disorders, and diagnosing MOGS-CDG can be challenging due to its clinical heterogeneity and lack of detection by transferrin screening. This study clinically characterized ten MOGS-CDG cases, including six previously unreported individuals, and identified a common phenotype characterized by dysmorphic features, developmental delay, muscular hypotonia, seizures, and in some cases vision problems and hypogammaglobulinemia. A quantitative method using liquid chromatography-mass spectrometry was developed to analyze urinary Glc(3)Man and successfully diagnosed MOGS-CDG in all six analyzed cases.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Review Biochemistry & Molecular Biology

What matters to parents? A scoping review of parents' service experiences and needs regarding genetic testing for rare diseases

Erin Crellin, Melissa Martyn, Belinda McClaren, Clara Gaff

Summary: Patient care experiences play a crucial role in the successful implementation of genomics in paediatric care. A scoping review was conducted to understand parents' experiences and needs regarding genetic testing for rare diseases in their children. The review revealed that parents valued feeling cared for, consistent relationships with clinicians, empathic communication, updated information during the waiting period for test results, and access to support resources following result disclosure. Strategies to address unmet needs were proposed, but evidence on their effectiveness was limited. This emphasizes the need for rigorous interventions and the integration of genomics into paediatric care.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

Causation in cerebral palsy: Parental beliefs and associated emotions

Renee Smyth, Susan M. Reid, Kate Paton, Angela T. Guzys, Claire E. Wakefield, David J. Amor

Summary: The aim of this study was to understand parents' beliefs about the causes of cerebral palsy (CP) and the emotions related to those beliefs. A survey was conducted on 226 parents of children with CP aged 1 to 18 years. The majority of participants expressed the importance of understanding the causes of CP, but there was also uncertainty about the causes. The most commonly endorsed causal factors were intrapartum hypoxia, brain damage, and preterm birth, and parents often experienced feelings of anger, sadness, guilt, and confusion.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2023)

Article Genetics & Heredity

Alternative Genetic Diagnoses in Axenfeld-Rieger Syndrome Spectrum

Linda M. Reis, David J. Amor, Raad A. Haddad, Catherine B. Nowak, Kim M. Keppler-Noreuil, Smith Ann Chisholm, Elena V. Semina

Summary: Axenfeld-Rieger anomaly is an ocular disorder associated with other systemic abnormalities. This study identified pathogenic variants in nine families affecting five different genes/regions. USP9X and JAG1 were the most commonly mutated genes associated with the disorder. Variants in CDK13, BCOR, and an X chromosome deletion were also found to be linked with Axenfeld-Rieger syndrome.

GENES (2023)

Article Biochemistry & Molecular Biology

Defining the 3′Epigenetic Boundary of the FMR1 Promoter and Its Loss in Individuals with Fragile X Syndrome

David E. Godler, Yoshimi Inaba, Minh Q. Bui, David Francis, Cindy Skinner, Charles E. Schwartz, David J. Amor

Summary: This study characterizes the specific DNA methylation patterns of fragile X syndrome in blood and brain tissues, providing a novel avenue for the detection of the syndrome through DNA methylation analysis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Parents' preferences for receiving and discussing prognostic genetic information regarding their children's neurodevelopmental condition: A qualitative study

Erin Turbitt, Meg Bourne, Alison McEwen, David J. Amor

Summary: This study investigated parents' preferences and motivations for acquiring and discussing prognostic genetic test results. The findings showed that parents had varying levels of tolerance for prognostic uncertainty and focused more on their child's potential and challenges. However, they also expressed concerns about the potential loss of hope and societal stigma associated with prognostic information.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2023)

No Data Available